Table 2.
Variable | Change in cSBP, mmHg (95% CI) |
P value |
---|---|---|
TC, mmol/L | ||
Continuous, per 1 mmol/L | 1.20 (0.73–1.67) | < 0.001 |
Quartiles | ||
Q1: < 4.70 | Ref. | |
Q2: 4.70–< 5.28 | 0.72 (−0.57–2.00) | 0.274 |
Q3: 5.28–< 5.95 | 1.99 (0.71–3.28) | 0.002 |
Q4: ≥5.95 | 2.58 (1.28–3.88) | < 0.001 |
TG, mmol/L | ||
Continuous, per 1 mmol/L | 0.84 (0.49–1.19) | < 0.001 |
Quartiles | ||
Q1: < 0.87 | Ref. | |
Q2: 0.87–< 1.24 | 1.51 (0.23–2.80) | 0.021 |
Q3: 1.24–< 1.79 | 2.30 (0.98–3.61) | < 0.001 |
Q4: ≥1.79 | 4.22 (2.87–5.57) | < 0.001 |
HDL-C, mmol/L | ||
Continuous, per 1 mmol/L | −1.43 (−2.76– − 0.10) | 0.035 |
Quartiles | ||
Q1: < 1.19 | Ref. | |
Q2: 1.19–< 1.42 | −0.74 (−2.05–0.57) | 0.268 |
Q3: 1.42–< 1.68 | −1.00 (−2.36–0.36) | 0.151 |
Q4: ≥1.68 | −1.60 (−3.03– − 0.17) | 0.028 |
LDL-C, mmol/L | ||
Continuous, per 1 mmol/L | 1.00 (0.44–1.56) | < 0.001 |
Quartiles | ||
Q1: < 2.73 | Ref. | |
Q2: 2.73–< 3.24 | 1.40 (0.12–2.68) | 0.032 |
Q3: 3.24–< 3.78 | 1.35 (0.06–2.64) | 0.041 |
Q4: ≥3.78 | 2.63 (1.34–3.93) | < 0.001 |
Non-HDL-C, mmol/L | ||
Continuous, per 1 mmol/L | 1.38 (0.91–1.85) | < 0.001 |
Quartiles | ||
Q1: < 3.22 | Ref. | |
Q2: 3.22–< 3.83 | 2.33 (1.05–3.60) | < 0.001 |
Q3: 3.83–< 4.49 | 2.14 (0.85–3.43) | 0.001 |
Q4: ≥4.49 | 3.88 (2.57–5.18) | < 0.001 |
RLP-C, mmol/L | ||
Continuous, per 1 mmol/L | 3.94 (2.82–5.07) | < 0.001 |
Quartiles | ||
Q1: < 0.39 | Ref. | |
Q2: 0.39–< 0.54 | 1.62 (0.33–2.91) | 0.014 |
Q3: 0.54–< 0.73 | 2.19 (0.88–3.50) | 0.001 |
Q4: ≥0.73 | 4.88 (3.53–6.23) | < 0.001 |
Model adjusted for age, sex, body mass index, estimated glomerular filtration rate, smoking status, drinking status, diabetes mellitus, antidiabetic drug use, history of myocardial infarction and history of stroke
Abbreviations: TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, non-HDL-C non-high-density lipoprotein cholesterol, RLP-C remnant lipoprotein cholesterol, cSBP central systolic blood pressure